Bliss GVS Pharma Limited BLISSGVS

Latest filings

• General25 6 Nov, 15:59 · NSE
  Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ( SEBI Listing Regulations )
• General25 6 Nov, 15:50 · BSE
  Please find enclosed herewith the Intimation under Regulation 30 of the SEBI Listing Regulations.
• General25 4 Nov, 17:14 · NSE
  'Intimation under Regulations 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Grant of Marketing Authorisation from MHRA, UK for Mesalazine 1g Suppositories'.
• General25 4 Nov, 17:09 · BSE
  We wish to inform you that Asterisk Lifesciences Ltd, UK, a wholly owned subsidiary of Bliss GVS Pharma Limited, has obtained marketing authorization from the Medicines & Healthcare products ....
• Routine15 2 Nov, 13:25 · BSE
  Please find enclosed herewith the Newspaper Publication regarding Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026.
• Results73 29 Oct, 17:44 · NSE
  , the financial results for the period ended September 30, 2026.
• Board meeting45 29 Oct, 17:22 · BSE
  Please find enclosed herewith the outcome of Nomination and Remuneration Committee meeting held today i.e. on October 29, 2026, the members has granted 2,95,000 stock options under Bliss ....
• Board meeting50 29 Oct, 17:19 · BSE
  Please find enclosed herewith the Outcome of Board Meeting which was held on today i.e. October 29, 2026
• Board meeting50 29 Oct, 17:17 · BSE
  Please find enclosed herewith the Outcome of Board Meeting which was held on today i.e. October 29, 2026
• Results73 29 Oct, 17:00 · BSE
  Please find attached the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026.

Shown 15 minutes after publication. Real time with Pro.